Abbott Wins 'Urgent' Ban On Rival's Glucose Monitor Sales
The Unified Patent Court has hit a Chinese company with an interim ban on sales of glucose monitors that may infringe Abbott's patent, citing an "urgent" need for stop-gap measures in a decision...To view the full article, register now.
Already a subscriber? Click here to view full article